{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:42:46Z","timestamp":1765888966578,"version":"3.48.0"},"reference-count":47,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8640\/A23385"],"award-info":[{"award-number":["C8640\/A23385"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,8,12]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The faecal immunochemical test (FIT) was introduced to triage patients with lower-risk symptoms of colorectal cancer (CRC) in English primary care in 2018. While there is growing evidence on its utility to triage patients in this setting, evidence is still limited on how official FIT guidance is being used, for which patients and for what symptoms. We aimed to investigate the use of FIT in primary care practice for lower-risk patients who did not immediately meet criteria for urgent referral.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A prospective, descriptive study of symptomatic patients offered a FIT in primary care between January and June 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>East of England general practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Consenting patients (aged \u226540 years) who were seen by their general practitioners (GPs) with symptoms of possible CRC for whom a FIT was requested. We excluded patients receiving a FIT for asymptomatic screening purposes, or patients deemed by GPs as lacking capacity for informed consent. Data were obtained via patient questionnaire, medical and laboratory records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>FIT results (10\u2009\u00b5g Hb\/g faeces defined a positive result); patient sociodemographic and clinical characteristics; patient-reported and GP-recorded symptoms, symptom severity and symptom agreement between patient and GP (% and kappa statistics).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Complete data were available for 310 patients, median age 70 (IQR 61\u201377) years, 53% female and 23% FIT positive. Patients most commonly reported change in bowel habit (69%) and fatigue (57%), while GPs most commonly recorded abdominal pain (25%) and change in bowel habit (24%). Symptom agreement ranged from 44% (fatigue) to 80% (unexplained weight loss). Kappa agreement was universally low across symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Almost a quarter of this primary care cohort of symptomatic patients with FIT testing were found to be positive. However, there was low agreement between patient-reported and GP-recorded symptoms. This may impact cancer risk assessment and optimal patient management in primary care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-066051","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T13:10:52Z","timestamp":1663593052000},"page":"e066051","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Who are the patients being offered the faecal immunochemical test in routine English general practice, and for what symptoms? A prospective descriptive study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-2543","authenticated-orcid":false,"given":"Natalia","family":"Calanzani","sequence":"first","affiliation":[{"name":"The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-0570","authenticated-orcid":false,"given":"Merel M","family":"Pannebakker","sequence":"additional","affiliation":[{"name":"The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0341-3284","authenticated-orcid":false,"given":"Max J","family":"Tagg","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-9674","authenticated-orcid":false,"given":"Hugo","family":"Walford","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Holloway","sequence":"additional","affiliation":[{"name":"East of England Cancer Alliances, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niek","family":"de Wit","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-1373","authenticated-orcid":false,"given":"Willie","family":"Hamilton","sequence":"additional","affiliation":[{"name":"University of Exeter Medical School, University of Exeter, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7191-6476","authenticated-orcid":false,"given":"Fiona M","family":"Walter","sequence":"additional","affiliation":[{"name":"The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"},{"name":"Wolfson Institute of Population Health, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"2025121411363786000_12.9.e066051.1","unstructured":"GLOBOCAN . Estimated number of deaths worldwide, both sexes, all ages 2020, 2018. Available: https:\/\/gco.iarc.fr\/"},{"key":"2025121411363786000_12.9.e066051.2","unstructured":"National Cancer Registration and Analysis Service (NCRAS) , 2019. Routes to Diagnosis 2006-2016 workbook (a). Percentage of Diagnoses by route - 2006 to 2016. Available: http:\/\/www.ncin.org.uk\/view?rid=3814"},{"key":"2025121411363786000_12.9.e066051.3","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1093\/pubmed\/fdx188","article-title":"The nature and frequency of abdominal symptoms in cancer patients and their associations with time to help-seeking: evidence from a national audit of cancer diagnosis","volume":"40","author":"Koo","year":"2018","journal-title":"J Public Health"},{"key":"2025121411363786000_12.9.e066051.4","unstructured":"NICE . Suspected cancer: recognition and referral NICE guideline [NG12], 2015. Available: https:\/\/www.nice.org.uk\/guidance\/ng12"},{"key":"2025121411363786000_12.9.e066051.5","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1038\/sj.bjc.6605396","article-title":"The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients","volume":"101 Suppl 2","author":"Hamilton","year":"2009","journal-title":"Br J Cancer"},{"key":"2025121411363786000_12.9.e066051.6","unstructured":"NICE . Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care (DG30), 2017. Available: https:\/\/www.nice.org.uk\/guidance\/dg30"},{"key":"2025121411363786000_12.9.e066051.7","doi-asserted-by":"publisher","DOI":"10.3310\/hta21410"},{"key":"2025121411363786000_12.9.e066051.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5746-6","article-title":"Evaluating diagnostic strategies for early detection of cancer: the cantest framework","volume":"19","author":"Walter","year":"2019","journal-title":"BMC Cancer"},{"key":"2025121411363786000_12.9.e066051.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01221-9"},{"key":"2025121411363786000_12.9.e066051.10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0004563220935622","article-title":"Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral","volume":"57","author":"Digby","year":"2020","journal-title":"Ann Clin Biochem"},{"key":"2025121411363786000_12.9.e066051.11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/apt.15969","article-title":"Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests","volume":"52","author":"Nicholson","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121411363786000_12.9.e066051.12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/codi.14944","article-title":"Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham","volume":"22","author":"Chapman","year":"2020","journal-title":"Colorectal Dis"},{"key":"2025121411363786000_12.9.e066051.13","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00384-020-03672-1","article-title":"Qualitative faecal immunochemical tests (fits) for diagnosing colorectal cancer in patients with histories of rectal bleeding in primary care: a cohort study","volume":"35","author":"H\u00f6gberg","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"2025121411363786000_12.9.e066051.14","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X713465"},{"key":"2025121411363786000_12.9.e066051.15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41416-018-0178-7","article-title":"The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer","volume":"119","author":"Juul","year":"2018","journal-title":"Br J Cancer"},{"key":"2025121411363786000_12.9.e066051.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2019-000293"},{"key":"2025121411363786000_12.9.e066051.17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324856"},{"key":"2025121411363786000_12.9.e066051.18","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-321650","article-title":"Prioritisation by fit to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study","volume":"70","author":"Loveday","year":"2021","journal-title":"Gut"},{"key":"2025121411363786000_12.9.e066051.19","unstructured":"Office for National Statistics . Table SAPE22DT6a: Mid-2019 Population Estimates for 2020 Clinical Commissioning Groups in England by Single Year of Age and Sex, Persons - National Statistics, 2020. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/datasets\/clinicalcommissioninggroupmidyearpopulationestimates"},{"key":"2025121411363786000_12.9.e066051.20","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.221"},{"key":"2025121411363786000_12.9.e066051.21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2468-1253(16)30079-6","article-title":"Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (symptom pancreatic study): a prospective cohort study","volume":"1","author":"Walter","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121411363786000_12.9.e066051.22","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.30"},{"key":"2025121411363786000_12.9.e066051.23","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1617"},{"key":"2025121411363786000_12.9.e066051.24","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp13X668186"},{"key":"2025121411363786000_12.9.e066051.25","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2025121411363786000_12.9.e066051.26","unstructured":"ERICA TRIAL . Available: https:\/\/www.theericatrial.co.uk\/2022"},{"key":"2025121411363786000_12.9.e066051.27","unstructured":"Office for National Statistics . England and Wales 2011 census. population by ethnicity and region, 2018. Available: https:\/\/www.ethnicity-facts-figures.service.gov.uk\/uk-population-by-ethnicity\/national-and-regional-populations\/regional-ethnic-diversity\/latest\/downloads\/population-by-ethnicity-and-region.csv"},{"key":"2025121411363786000_12.9.e066051.28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.12788\/jcso.0080","article-title":"Patient and provider concordance on symptoms during the oncology outpatient clinic visit","volume":"12","author":"Chidambaram","year":"2014","journal-title":"J Community Support Oncol"},{"key":"2025121411363786000_12.9.e066051.29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaophthalmol.2016.5551","article-title":"Agreement of ocular symptom reporting between patient-reported outcomes and medical records","volume":"135","author":"Valikodath","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2025121411363786000_12.9.e066051.30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40487-019-0094-x","article-title":"Real-world impact of physician and patient discordance on health-related quality of life in US patients with acute myeloid leukemia","volume":"7","author":"Horvath Walsh","year":"2019","journal-title":"Oncol Ther"},{"key":"2025121411363786000_12.9.e066051.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00264-0"},{"key":"2025121411363786000_12.9.e066051.32","first-page":"530","article-title":"Agreement between patient-reported symptoms and their documentation in the medical record","volume":"14","author":"Pakhomov","year":"2008","journal-title":"Am J Manag Care"},{"key":"2025121411363786000_12.9.e066051.33","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-020-01194-x"},{"key":"2025121411363786000_12.9.e066051.34","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1038\/bjc.2015.44","article-title":"A differentiated approach to referrals from general practice to support early cancer diagnosis - the danish three-legged strategy","volume":"112 Suppl 1","author":"Vedsted","year":"2015","journal-title":"Br J Cancer"},{"key":"2025121411363786000_12.9.e066051.35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/codi.16120","article-title":"The use of the faecal immunochemical test during the COVID-19 pandemic to triage urgent colorectal cancer referrals","volume":"24","author":"Kamel","year":"2022","journal-title":"Colorectal Dis"},{"key":"2025121411363786000_12.9.e066051.36","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2021-101825"},{"key":"2025121411363786000_12.9.e066051.37","doi-asserted-by":"publisher","DOI":"10.3399\/BJGPO.2021.0056"},{"key":"2025121411363786000_12.9.e066051.38","article-title":"Faecal immunochemical test for suspected colorectal cancer symptoms: patient survey of usability and acceptability","volume":"60102","author":"Georgiou Delisle","year":"2022","journal-title":"BJGP Open"},{"key":"2025121411363786000_12.9.e066051.39","unstructured":"NHS England . Clinical guide for triaging patients with lower gastrointestinal symptoms, 2020. Available: https:\/\/www.nice.org.uk\/Media\/Default\/About\/COVID-19\/Specialty-guides\/triaging-patients-with-lower-gi-symptoms.pdf"},{"key":"2025121411363786000_12.9.e066051.40","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2020.1098"},{"key":"2025121411363786000_12.9.e066051.41","unstructured":"Guideline Development Group (GDG) . Faecal Immunochemical Testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): A joint guideline from the Association of Coloproctology of Great Britain & Ireland (ACPGBI) and the British Society of Gastroenterology (BSG); 2022. https:\/\/www.bsg.org.uk\/clinical-resource\/faecal-immunochemical-testing-fit-in-patients-with-signs-or-symptoms-of-suspected-colorectal-cancer-crc-a-joint-guideline-from-the-acpgbi-and-the-bsg\/"},{"key":"2025121411363786000_12.9.e066051.42","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327985","article-title":"Faecal immunochemical testing (fit) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the association of Coloproctology of great britain and ireland (ACPGBI) and the British Society of gastroenterology (Bsg)","author":"Monahan","year":"2022","journal-title":"Gut"},{"key":"2025121411363786000_12.9.e066051.43","unstructured":"National Institute for Health and Care Excellence . Quantitative Faecal Immunochemical Tests to guide colorectal cancer pathway referral for people with a change in bowel habit or abdominal pain - GID-DG10036, 2022. Available: https:\/\/www.nice.org.uk\/guidance\/indevelopment\/gid-dg10036"},{"key":"2025121411363786000_12.9.e066051.44","unstructured":"Norfolk and Norwich University Hospitals . Guideline for the triage and diagnostic investigation of patients referred with suspected colorectal cancer. Available: www.nnuh.nhs.uk2020"},{"key":"2025121411363786000_12.9.e066051.45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0004563220967569","article-title":"Faecal immunochemical tests in the COVID-19 pandemic; safety-netting of patients with symptoms and low faecal haemoglobin concentration - can a repeat test be used?","volume":"58","author":"Benton","year":"2021","journal-title":"Ann Clin Biochem"},{"key":"2025121411363786000_12.9.e066051.46","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp22X720209"},{"key":"2025121411363786000_12.9.e066051.47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41416-021-01653-x","article-title":"Faecal immunochemical test for patients with 'high-risk' bowel symptoms: a large prospective cohort study and updated literature review","volume":"126","author":"Laszlo","year":"2022","journal-title":"Br J Cancer"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-066051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T19:36:46Z","timestamp":1765741006000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-066051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,19]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/bmjopen-2022-066051"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-066051","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}